Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor

This publication has 21 references indexed in Scilit:

• Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
  Journal of Clinical Investigation, 1991
• Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cells
  Biochemical Pharmacology, 1990
• Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systems
  Pharmacology & Therapeutics, 1990
• The Effect of DNA Polymerase Inhibitors on the Cytotoxicity of Cisplatin in Human Ovarian Carcinoma Cells
  Cancer Communications, 1990
• Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin
  Biochemical Pharmacology, 1988
• W‐7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells
  International Journal of Cancer, 1987
• Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong VS weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells
  Biochemical and Biophysical Research Communications, 1985
• Inhibition of DNA repair by trifluoperazine
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1985
• Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro
  Biochemical and Biophysical Research Communications, 1984
• Potentiation of Bleomycin Lethality by Anticalmodulin Drugs: A Role for Calmodulin in DNA Repair
  Science, 1984